Browsing by Subject "Progression-free survival"
Now showing items 1-5 of 5
-
Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
(Brac University, 2023-11)Renal cell carcinoma (RCC) is the predominant form of kidney cancer. It is a highly prevalent form of solid tumor, and the limited availability of accurate disease models has impeded progress in the field of human kidney ... -
Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
(Brac University, 2023-11)Hepatocellular carcinoma (HCC) is an important healthcare problem with developing therapeutic options. This meta-analysis evaluates the effectiveness and safety of lenvatinib and sorafenib, focusing largely on overall ... -
An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
(Brac University, 2024-02)The treatment of colon cancer is a major healthcare issue that requires exploration of several treatment approaches. With an emphasis on overall survival, progression-free survival, and adverse events, this meta-analysis ... -
Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
(Brac University, 2024-05)Metastatic breast cancer requires more investigation because of its high incidence. Efforts to improve the accessibility, evaluative simplicity, and predictive accuracy of clinical trial endpoints are ongoing. In this ... -
A systematic review on the comparison of the safety and efficacy of temozolomide and radiotherapy along with another drug combination in the treatment of glioblastoma multiforme
(Brac University, 2022-03)Glioblastoma multiforme is one of the most dangerous primary brain tumors, with a poor prognosis even after vigorous treatment. Neurosurgical enhancements, the discovery of potent chemotherapeutic medicines, developments ...
